Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (276)
Aquestive Therapeutics, Inc. (AQST)
Barber Daniel — President and CEO
Shares
4,631
Price
$4.03
Total Value
$18.68K
Shares Held After
630,943
% of Holdings
0.7%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
1,389
Price
$1.55
Total Value
$2.15K
Shares Held After
75,017
% of Holdings
1.9%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
13,761
Price
$1.55
Total Value
$21.33K
Shares Held After
743,038
% of Holdings
1.9%
Butterfly Network, Inc. (BFLY)
ROTHBERG JONATHAN M — Director
Shares
1,730,319
Price
$7.32
Total Value
$12.67M
Shares Held After
359,748
% of Holdings
82.8%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
1,600
Price
$2.44
Total Value
$3.90K
Shares Held After
2,835,581
% of Holdings
0.1%
GILEAD SCIENCES, INC. (GILD)
Dickinson Andrew D — Chief Financial Officer
Shares
3,000
Price
$129.93
Total Value
$389.78K
Shares Held After
168,646
% of Holdings
1.7%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm&Corp Aff Officer
Shares
3,000
Price
$129.92
Total Value
$389.76K
Shares Held After
121,234
% of Holdings
2.4%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
53,336
Price
$67.60
Total Value
$3.61M
Shares Held After
1,483,848
% of Holdings
3.5%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Wai Conrad — CEO, Counterpart Health
Shares
24,215
Price
$4.67
Total Value
$113.08K
Shares Held After
1,145,699
% of Holdings
2.1%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
THORNTON JOSEPH CLAY — Interim CFO
Shares
4,630
Price
$4.67
Total Value
$21.62K
Shares Held After
1,212,954
% of Holdings
0.4%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Soares Karen — Chief Legal Officer
Shares
10,519
Price
$4.67
Total Value
$49.12K
Shares Held After
1,557,222
% of Holdings
0.7%
Alignment Healthcare, Inc. (ALHC)
Maroney Dawn Christine — President
Shares
177,068
Price
$20.83
Total Value
$3.69M
Shares Held After
922,313
% of Holdings
16.1%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Toy Andrew — Director
Shares
62,711
Price
$4.67
Total Value
$292.86K
Shares Held After
9,547,114
% of Holdings
0.7%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
13,119
Price
$4.67
Total Value
$61.27K
Shares Held After
2,819,479
% of Holdings
0.5%
DEXCOM INC (DXCM)
Brown Michael Jon — EVP Chief Legal Compliance Off
Shares
1,700
Price
$74.42
Total Value
$126.51K
Shares Held After
104,653
% of Holdings
1.6%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
4,351
Price
$23.38
Total Value
$101.73K
Shares Held After
62,371
% of Holdings
6.5%
BRUKER CORP (BRKR)
Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Shares
2,000
Price
$60.25
Total Value
$120.50K
Shares Held After
128,443
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$534.27
Total Value
$64.11K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
825
Price
$533.08
Total Value
$439.79K
Shares Held After
324,563
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,295
Price
$531.97
Total Value
$1.75M
Shares Held After
325,388
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,044
Price
$531.03
Total Value
$554.39K
Shares Held After
328,683
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
577
Price
$530.12
Total Value
$305.88K
Shares Held After
329,727
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
641
Price
$529.03
Total Value
$339.11K
Shares Held After
330,304
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$527.77
Total Value
$63.33K
Shares Held After
330,945
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$525.24
Total Value
$147.07K
Shares Held After
331,065
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$524.40
Total Value
$230.73K
Shares Held After
331,345
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
203
Price
$523.20
Total Value
$106.21K
Shares Held After
331,785
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
189
Price
$521.84
Total Value
$98.63K
Shares Held After
331,988
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
48
Price
$520.92
Total Value
$25.00K
Shares Held After
332,177
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$534.09
Total Value
$21.36K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$533.22
Total Value
$85.31K
Shares Held After
40,553
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$532.06
Total Value
$425.65K
Shares Held After
40,713
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
278
Price
$530.97
Total Value
$147.61K
Shares Held After
41,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$529.66
Total Value
$63.56K
Shares Held After
41,791
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$527.55
Total Value
$21.10K
Shares Held After
41,911
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$525.42
Total Value
$42.03K
Shares Held After
41,951
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$523.97
Total Value
$62.88K
Shares Held After
42,031
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$521.82
Total Value
$41.75K
Shares Held After
42,151
% of Holdings
0.2%
INCYTE CORP (INCY)
Stein Steven H — CMO&Head of Late-Stage Dev.
Shares
28,237
Price
$113.05
Total Value
$3.19M
Shares Held After
26,083
% of Holdings
52.0%
Vivani Medical, Inc. (VANI)
Williams Gregg — Director
Shares
793,650
Price
$1.26
Total Value
$1000.00K
Shares Held After
36,912,736
% of Holdings
2.2%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
2,797
Price
$3.28
Total Value
$9.17K
Shares Held After
974,967
% of Holdings
0.3%
Personalis, Inc. (PSNL)
Chen Richard — President and CMO
Shares
100,000
Price
$15.15
Total Value
$1.51M
Shares Held After
173,880
% of Holdings
36.5%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,349
Price
$26.61
Total Value
$168.95K
Shares Held After
51,384
% of Holdings
11.0%
Fulcrum Therapeutics, Inc. (FULC)
TANG KEVIN — 10% Owner
Shares
107,377
Price
$3.56
Total Value
$382.26K
Shares Held After
6,913,329
% of Holdings
1.6%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
300
Price
$87.25
Total Value
$26.18K
Shares Held After
32,718
% of Holdings
0.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
3,803
Price
$86.68
Total Value
$329.63K
Shares Held After
33,018
% of Holdings
10.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,497
Price
$85.86
Total Value
$214.39K
Shares Held After
36,821
% of Holdings
6.4%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
400
Price
$84.36
Total Value
$33.75K
Shares Held After
39,318
% of Holdings
1.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,500
Price
$0.86
Total Value
$1.29K
Shares Held After
368,385
% of Holdings
0.4%
VIVOS INC (RDGL)
Korenko Michael K — Director
Shares
200,000
Price
$0.06
Total Value
$11.42K
Shares Held After
11,285,090
% of Holdings
1.8%
Showing 101–150 of 276 transactions (page 3 of 6)